Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
First Exposure to Deutetrabenazine Well-Tolerated Across Patient Populations
01/11/2022
Jolynn Tumolo
Analysis of safety data for deutetrabenazine suggests the drug is generally safe and well-tolerated in both tardive dyskinesia and chorea associated with Huntington's disease patient populations.
Analysis of safety data for deutetrabenazine suggests the drug is generally safe and well-tolerated in both tardive dyskinesia and chorea associated with Huntington's disease patient populations.
Analysis of safety data for...
01/11/2022
Psych Congress Network
News
Mood Disorders Associated With Significant ADHD Risk
01/11/2022
Jolynn Tumolo
ADHD is 3 times more common in people with mood disorders compared to people without mood disorders, according to findings from a systematic review and meta-analysis.
ADHD is 3 times more common in people with mood disorders compared to people without mood disorders, according to findings from a systematic review and meta-analysis.
ADHD is 3 times more common in...
01/11/2022
Psych Congress Network
News
Multiple Hypotension Drugs Recalled
01/07/2022
Jolynn Tumolo
Two vasoconstrictors are being recalled over sterility concerns.
Two vasoconstrictors are being recalled over sterility concerns.
Two vasoconstrictors are being...
01/07/2022
Pharmacy Learning Network
News
Vasopressor Injection Recalled
01/07/2022
Jolynn Tumolo
More than 43,000 bags of epinephrine are under a Class II recall.
More than 43,000 bags of epinephrine are under a Class II recall.
More than 43,000 bags of...
01/07/2022
Pharmacy Learning Network
News
Sodium Bicarbonate IV Bags Recalled
01/07/2022
Jolynn Tumolo
A prescription alkalinizing agent is under a Class II recall due to lack of sterility assurance.
A prescription alkalinizing agent is under a Class II recall due to lack of sterility assurance.
A prescription alkalinizing...
01/07/2022
Pharmacy Learning Network
News
Risk of COVID-19 Death Nearly 4 Times Higher in People with Schizophrenia
01/06/2022
Jolynn Tumolo
People with schizophrenia had higher odds of dying from COVID-19 but had significantly lower rates of testing positive for COVID-19 compared with the general population.
People with schizophrenia had higher odds of dying from COVID-19 but had significantly lower rates of testing positive for COVID-19 compared with the general population.
People with schizophrenia had...
01/06/2022
Psych Congress Network
News
Specific Brain Pathways Predict ADHD Impulsivity
01/04/2022
Jolynn Tumolo
Impulsivity differences in young people with ADHD can be predicted by the limbic and executive meso- and nigrostriatal tracts in the brain, suggest study findings published online ahead of print.
Impulsivity differences in young people with ADHD can be predicted by the limbic and executive meso- and nigrostriatal tracts in the brain, suggest study findings published online ahead of print.
Impulsivity differences in young...
01/04/2022
Psych Congress Network
News
OTC Antihistamine Tablets Recalled
12/29/2021
Jolynn Tumolo
A medication used to relieve allergy symptoms is being recalled for failure to meet impurity/degradation specifications.
A medication used to relieve allergy symptoms is being recalled for failure to meet impurity/degradation specifications.
A medication used to relieve...
12/29/2021
Pharmacy Learning Network
News
Antibiotic Recalled
12/29/2021
Jolynn Tumolo
Over 100,000 bottles of penicillin V potassium are under a Class II recall due to subpotency.
Over 100,000 bottles of penicillin V potassium are under a Class II recall due to subpotency.
Over 100,000 bottles of...
12/29/2021
Pharmacy Learning Network
News
OTC Cold & Flu Meds Recalled
12/29/2021
Jolynn Tumolo
A Class II recall has been issued for four over-the-counter medications used to treat symptoms of the flu and common cold.
A Class II recall has been issued for four over-the-counter medications used to treat symptoms of the flu and common cold.
A Class II recall has been...
12/29/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use